United Therapeutics
UTHR
#1127
Rank
C$30.59 B
Marketcap
C$713.34
Share price
-0.73%
Change (1 day)
72.11%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): C$40.40

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is C$40.87. In 2025 the company made an earnings per share (EPS) of C$42.07 an increase over its 2024 EPS that were of C$36.87.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$40.40-3.97%
2025C$42.0714.1%
2024C$36.8725.59%
2023C$29.3631.54%
2022C$22.3251.18%
2021C$14.76-9.1%
2020C$16.24-581.4%
2019C-$3.37-117.79%
2018C$18.9642.11%
2017C$13.34-40.93%
2016C$22.5813.45%
2015C$19.91104.29%
2014C$9.74100.29%
2013C$4.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.83-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.35-3.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.97-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.34-74.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
C$9.16-77.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.42-86.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
C-$9.54-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.91-95.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel